Correlation Between Enveric Biosciences and Catalyst Biosciences
Can any of the company-specific risk be diversified away by investing in both Enveric Biosciences and Catalyst Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enveric Biosciences and Catalyst Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enveric Biosciences and Catalyst Biosciences, you can compare the effects of market volatilities on Enveric Biosciences and Catalyst Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enveric Biosciences with a short position of Catalyst Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enveric Biosciences and Catalyst Biosciences.
Diversification Opportunities for Enveric Biosciences and Catalyst Biosciences
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Enveric and Catalyst is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Enveric Biosciences and Catalyst Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Biosciences and Enveric Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enveric Biosciences are associated (or correlated) with Catalyst Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Biosciences has no effect on the direction of Enveric Biosciences i.e., Enveric Biosciences and Catalyst Biosciences go up and down completely randomly.
Pair Corralation between Enveric Biosciences and Catalyst Biosciences
Given the investment horizon of 90 days Enveric Biosciences is expected to under-perform the Catalyst Biosciences. In addition to that, Enveric Biosciences is 1.58 times more volatile than Catalyst Biosciences. It trades about -0.01 of its total potential returns per unit of risk. Catalyst Biosciences is currently generating about 0.06 per unit of volatility. If you would invest 31.00 in Catalyst Biosciences on September 3, 2024 and sell it today you would earn a total of 10.00 from holding Catalyst Biosciences or generate 32.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 30.91% |
| Values | Daily Returns |
Enveric Biosciences vs. Catalyst Biosciences
Performance |
| Timeline |
| Enveric Biosciences |
| Catalyst Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Enveric Biosciences and Catalyst Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enveric Biosciences and Catalyst Biosciences
The main advantage of trading using opposite Enveric Biosciences and Catalyst Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enveric Biosciences position performs unexpectedly, Catalyst Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Biosciences will offset losses from the drop in Catalyst Biosciences' long position.| Enveric Biosciences vs. Ocean Biomedical | Enveric Biosciences vs. Hepion Pharmaceuticals | Enveric Biosciences vs. Elevation Oncology | Enveric Biosciences vs. Zura Bio Limited |
| Catalyst Biosciences vs. Akari Therapeutics PLC | Catalyst Biosciences vs. Benitec Biopharma Ltd | Catalyst Biosciences vs. Pulmatrix |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |